All In Biotech

Drug Trial Radar · NCT07030868

A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes

A Phase 2, Parallel-Group, Double-Blind 4-arm Study to Investigate the Effects of Treatment With LY3549492 Tablets Compared With Placebo in an Obese or Overweight Population With Type-2 Diabetes (T2D)

Last checked: Nov 19, 2026Latest source record: Aug 31, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

1

Actual

Start

Jun 19, 2025

Primary completion

Jul 29, 2025

Study completion Jul 29, 2025

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Jun 22, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study, performed under the master protocol W8M-MC-CWMM (NCT06143956), is to evaluate the effects of treatment with LY3549492 compared to placebo in adult participants with obesity or who are overweight with type 2 diabetes. Participation in the study will last about 11 months.

Conditions

  • Obesity
  • Overweight
  • Type 2 Diabetes

Interventions

  • LY3549492Drug

    Administered orally

  • PlaceboDrug

    Administered orally

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent Change From Baseline in Body WeightTime frame: Baseline, Week 32

Locations

42 sites in 2 countries. Site status is shown where the registry gives one.

  • HOPE Research Institute

    Phoenix, Arizona

  • Headlands Research - Scottsdale

    Scottsdale, Arizona

  • NorCal Medical Research, Inc

    Greenbrae, California

  • Velocity Clinical Research, Huntington Park

    Huntington Park, California

  • Peninsula Research Associates

    Rolling Hills Estates, California

  • Diablo Clinical Research, Inc.

    Walnut Creek, California

  • Stamford Therapeutics Consortium

    Stamford, Connecticut

  • Northeast Research Institute (NERI)

    Fleming Island, Florida

  • Indago Research & Health Center, Inc

    Hialeah, Florida

  • New Horizon Research Center

    Miami, Florida

  • Suncoast Clinical Research, Inc.

    New Port Richey, Florida

  • Charter Research - Winter Park

    Orlando, Florida

  • Charter Research - Lady Lake

    The Villages, Florida

  • Medical Research Partners

    Ammon, Idaho

  • Great Lakes Clinical Trials - Ravenswood

    Chicago, Illinois

  • Iowa Diabetes and Endocrinology Research Center

    West Des Moines, Iowa

  • Cotton O'Neil Diabetes & Endocrinology

    Topeka, Kansas

  • Knownwell

    Needham, Massachusetts

  • Lucida Clinical Trials

    New Bedford, Massachusetts

  • Headlands Research - Detroit

    Southfield, Michigan

  • Arcturus Healthcare , PLC, Troy Internal Medicine Research Division

    Troy, Michigan

  • Clinvest Headlands Llc

    Springfield, Missouri

  • Las Vegas Medical Research

    Las Vegas, Nevada

  • Velocity Clinical Research, Syracuse

    East Syracuse, New York

  • Rochester Clinical Research, LLC

    Rochester, New York

  • Monroe Biomedical Research

    Monroe, North Carolina

  • Lucas Research, Inc

    Morehead City, North Carolina

  • Lucas Research, Inc.

    New Bern, North Carolina

  • Quality Medical Research

    Nashville, Tennessee

  • IMA Clinical Research Austin

    Austin, Texas

  • Velocity Clinical Research, Dallas

    Dallas, Texas

  • FutureSearch Trials of Dallas

    Dallas, Texas

  • PlanIt Research, PLLC

    Houston, Texas

  • Tekton Research - Fredericksburg Road

    San Antonio, Texas

  • Endeavor Clinical Trials

    San Antonio, Texas

  • Texas Valley Clinical Research

    Weslaco, Texas

  • Spectrum Medical, Inc.

    Danville, Virginia

  • Central Washington Health Services Association d/b/a Confluence Health

    Wenatchee, Washington

  • Centro de Investigaciones Metabólicas (CINME)

    Buenos Aires, Argentina

  • Centro Médico Viamonte

    Buenos Aires, Buenos Aires F.D., Argentina

Showing 40 of 42 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.